BioCompLab

Peir-In Liang (連培因)

Ph.D. Student (2016/09-2022/08)

PhD Program in Toxicology,
Kaohsiung Medical University, Taiwan
Email:

Scientific Publications


  1. P.I. Liang, C.C. Wang, H.J. Cheng, S.S. Wang, Y.C. Lin, P. Lin* and C.W. Tung* (2020) Curation of cancer hallmark-based genes and pathways for in silico characterization of chemical carcinogenesis, Database (Oxford), 2020, baaa045.
  2. Y.L. Lin*, W.E. Huang, P.I. Liang and C.W. Tung (2018) An Integrated Web-based System for MEDLINE Analysis: A Case Study of Chronic Kidney Disease, Proceedings of 22nd Pacific Asia Conference on Information Systems (PACIS 2018), 1828-1840.

Conference Presentations


  1. P.I. Liang, C.C. Wang, S.S. Wang, Y.C. Lin* and C.W. Tung* (2022) Analysis of hallmarks of cancer initiated after exposure to non-genotoxic hepatocarcinogens using toxicogenomics data, The 20th Asia Pacific Bioinformatics Conference (APBC2022), Malaysia. Apr 26-28 (Poster).
  2. Y.L. Lin*, W.E. Huang, P.I. Liang and C.W. Tung (2018) An Integrated Web-based System for MEDLINE Analysis: A Case Study of Chronic Kidney Disease, 22nd Pacific Asia Conference on Information Systems (PACIS 2018), Yokohama, Japan. Jun 26-30 (Oral).

Other Publications


  1. P.I. Liang (2022) Developing a toxicogenomics system for evaluating chemical carcinogenicity based on cancer hallmarks, PhD thesis, PhD Program in Toxicology, Kaohsiung Medical University.